Literature DB >> 24103300

Synthesis and immunological activity of an oligosaccharide-conjugate as a vaccine candidate against Group A Streptococcus.

France-Isabelle Auzanneau1, Silvia Borrelli, B Mario Pinto.   

Abstract

The synthesis and immunogenicity of a tetanus toxoid (TT)-conjugate of the hexasaccharide portion of the cell-wall polysaccharide (CWPS) of the Group A Streptococcus (GAS) is described. The synthesis relies on the reaction of an allyl glycoside of the hexasaccharide with cysteamine, followed by the reaction of the resultant amine with diethyl squarate to give the monoethyl squarate adduct. Subsequent reaction with the lysine ε-amino groups on TT gives the glycoconjugate containing 30 hexasaccharide haptens per TT molecule. The immunogenicity in mice is similar to that obtained with a native CWPS-TT conjugate, validating the glycoconjugate as a vaccine candidate against GAS infections.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell-wall polysaccharide; Glycoconjugate; Group A Streptococcus; Immunogenicity; Vaccine candidate

Mesh:

Substances:

Year:  2013        PMID: 24103300     DOI: 10.1016/j.bmcl.2013.09.042

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.

Authors:  Peng Xu; Meagan Kelly; Willie F Vann; Firdausi Qadri; Edward T Ryan; Pavol Kováč
Journal:  Chembiochem       Date:  2017-03-23       Impact factor: 3.164

2.  Novel platform technology for modular mucosal vaccine that protects against streptococcus.

Authors:  Mehfuz Zaman; Victoria Ozberk; Emma L Langshaw; Virginia McPhun; Jessica L Powell; Zachary N Phillips; Mei Fong Ho; Ainslie Calcutt; Michael R Batzloff; Istvan Toth; Geoffrey R Hill; Manisha Pandey; Michael F Good
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

3.  Immunogenicity Assessment of Different Segments and Domains of Group a Streptococcal C5a Peptidase and Their Application Potential as Carrier Protein for Glycoconjugate Vaccine Development.

Authors:  Guirong Wang; Jielin Zhao; Yisheng Zhao; Subo Wang; Shaojie Feng; Guofeng Gu
Journal:  Vaccines (Basel)       Date:  2021-02-09

Review 4.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

Review 5.  Glyconanoparticles as tools to prevent antimicrobial resistance.

Authors:  Laura Morelli; Laura Polito; Barbara Richichi; Federica Compostella
Journal:  Glycoconj J       Date:  2021-03-17       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.